earnings
NV
NASDAQ · NVAX
Novavax, Inc.
Healthcare · Biotechnology
$12.56
Down-$1.24 (-9.87%)
Updated Oct 6, 2026, 9:44 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 3.18
- Dividend yield
- 0.00%
- 52-week range
- $7.15 – $13.39
- Volume
- 28.7M
- Avg. volume
- 4.26M
Price performance · NVAX
NVAX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
NVAX closed at $12.56 after 20 trading sessions, up 23.26% for the selected period.
- Last close
- $12.56
- Period change
- +23.26%
- Period low
- $9.23
- Period high
- $12.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $10.47 | $13.385 | $10.275 | $12.56 | 28.7M |
| Oct 2, 2026 | $10.80 | $10.86 | $10.33 | $10.46 | 4.03M |
| Oct 1, 2026 | $10.75 | $10.98 | $10.545 | $10.60 | 3.15M |
| Sep 30, 2026 | $10.85 | $11.095 | $10.54 | $10.81 | 4.57M |
| Sep 29, 2026 | $10.80 | $11.1099 | $10.41 | $10.82 | 4.07M |
| Sep 28, 2026 | $10.495 | $10.975 | $10.26 | $10.80 | 4.46M |
| Sep 25, 2026 | $10.62 | $10.79 | $10.335 | $10.63 | 3.91M |
| Sep 24, 2026 | $10.425 | $10.85 | $10.38 | $10.60 | 4.35M |
| Sep 23, 2026 | $10.79 | $10.945 | $10.465 | $10.55 | 5.77M |
| Sep 22, 2026 | $10.39 | $11.09 | $10.15 | $10.83 | 7.58M |
| Sep 21, 2026 | $10.38 | $10.70 | $10.21 | $10.41 | 6.14M |
| Sep 18, 2026 | $9.89 | $10.145 | $9.76 | $10.11 | 11.15M |
| Sep 17, 2026 | $9.615 | $10.38 | $9.61 | $10.00 | 8.88M |
| Sep 16, 2026 | $9.35 | $9.41 | $9.155 | $9.35 | 2.85M |
| Sep 15, 2026 | $9.50 | $9.56 | $9.16 | $9.23 | 3.33M |
| Sep 14, 2026 | $9.38 | $9.60 | $9.135 | $9.59 | 3.37M |
| Sep 11, 2026 | $9.29 | $9.865 | $9.23 | $9.42 | 6.12M |
| Sep 10, 2026 | $9.64 | $9.68 | $9.11 | $9.30 | 5.89M |
| Sep 9, 2026 | $10.02 | $10.242 | $9.73 | $9.85 | 4.44M |
| Sep 8, 2026 | $10.099 | $10.3599 | $9.75 | $10.19 | 4.23M |
Latest NVAX news
The latest Smart Investors Daily articles mentioning NVAX.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…